Archive: 06/12/2017
Adjuvant Trastuzumab did not improve outcomes for patients with HER2-low breast cancer
Adding trastuzumab (Herceptin) to standard adjuvant chemotherapy did not improve invasive disease–free survival for patients with early-stage breast cancer found to have low levels of HER2, as defined as immunohistochemistry ...
Dec 6, 2017
Increasing the dose intensity of chemotherapy may lower the risk of breast cancer recurrence and death
Increasing the dose intensity of chemotherapy by either shortening the intervals between the cycles or by sequential administration instead of concurrent administration of the drugs reduced the risk of early-stage breast ...
Dec 6, 2017
New dissertation on the treatment of malignant melanoma
Malignant melanoma is one of the most common causes of cancer deaths among young adults. Although treatment for melanoma has improved in recent years, most patients do not benefit from the treatment, which also often causes ...
Dec 6, 2017
A South American amphibian could potentially hold the key in curing cirrhosis
The unique liver function of a South American amphibian, Siphonops annulatus, could pave the way to finding a cure to the devastating liver condition cirrhosis, a new study published in the prestigious Journal of Anatomy ...
Dec 6, 2017
Study examines safety and effectiveness of infliximab biosimilar in patients with inflammatory bowel disease
Biosimilars are biologic agents that highly similar to original biomedical medications (originators), but are much cheaper. A new study in Alimentary Pharmacology & Therapeutics found no differences in drug levels and disease ...
Dec 6, 2017